| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $450M | — | $271M | — | 66.1% |
| Op. Income | $177M | — | $82M | — | 115.0% |
| Gross Margin | 85.4% | — | 62.0% | — | 23.4pp |
| Net Margin | 29.6% | — | 29.0% | — | 0.6pp |
| EPS (Diluted) | $3.72 | — | $2.19 | — | 69.9% |
| Free Cash Flow | $208M | — | $39M | — | 428.3% |
| Item | Amount |
|---|---|
| REVENUE | $450M |
| Cost of Revenue | $66M |
| GROSS PROFIT | $384M |
| R&D Expenses | $0 |
| Selling & Marketing | $32M |
| General & Administrative | $17M |
| SG&A Expenses | $49M |
| Other Expenses | $159M |
| Operating Expenses | $208M |
| Cost & Expenses | $273M |
| OPERATING INCOME | $177M |
| Interest Income | $0 |
| Interest Expense | $14M |
| Other Income/Expenses | -$14M |
| INCOME BEFORE TAX | $163M |
| Income Tax Expense | $30M |
| Net Income from Continuing Ops | $133M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $133M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $133M |
| D&A | $1M |
| EBIT | $177M |
| EBITDA | $178M |
| EPS | $4 |
| EPS Diluted | $4 |
| Item | Amount |
|---|---|
| REVENUE | $450M |
| Cost of Revenue | $66M |
| GROSS PROFIT | $384M |
| R&D Expenses | $0 |
| Selling & Marketing | $32M |
| General & Administrative | $17M |
| SG&A Expenses | $49M |
| Other Expenses | $159M |
| Operating Expenses | $208M |
| Cost & Expenses | $273M |
| OPERATING INCOME | $177M |
| Interest Income | $0 |
| Interest Expense | $14M |
| Other Income/Expenses | -$14M |
| INCOME BEFORE TAX | $163M |
| Income Tax Expense | $30M |
| Net Income from Continuing Ops | $133M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $133M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $133M |
| D&A | $1M |
| EBIT | $177M |
| EBITDA | $178M |
| EPS | $4 |
| EPS Diluted | $4 |
| Item | Amount |
|---|---|
| Net Income | $133M |
| Depreciation & Amortization | $1M |
| Stock-Based Compensation | $7M |
| Deferred Income Tax | $3M |
| Other Non-Cash Items | $123M |
| Change in Working Capital | -$57M |
| OPERATING CASH FLOW | $210M |
| Capital Expenditure | -$2M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$181M |
| NET CASH FROM INVESTING | -$182M |
| Net Debt Issuance | $13M |
| Common Stock Repurchased | -$65M |
| Common Dividends Paid | $0 |
| Other Financing Activities | $22M |
| NET CASH FROM FINANCING | -$25M |
| FREE CASH FLOW | $208M |
| Net Change in Cash | $4M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $64M |
| Short-Term Investments | $0 |
| Net Receivables | $255M |
| Inventory | $0 |
| Other Current Assets | $33M |
| TOTAL CURRENT ASSETS | $352M |
| PP&E (Net) | $665.0K |
| Goodwill | $0 |
| Intangible Assets | $3M |
| Long-Term Investments | $0 |
| Tax Assets | $14M |
| Other Non-Current Assets | $31M |
| TOTAL NON-CURRENT ASSETS | $48M |
| TOTAL ASSETS | $400M |
| Account Payables | $56M |
| Short-Term Debt | $0 |
| Deferred Revenue | $5M |
| Other Current Liabilities | $28M |
| TOTAL CURRENT LIABILITIES | $90M |
| Long-Term Debt | $141M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $0 |
| TOTAL NON-CURRENT LIABILITIES | $141M |
| TOTAL LIABILITIES | $230M |
| Common Stock | $195M |
| Additional Paid-In Capital | $0 |
| Retained Earnings | -$324.0K |
| Treasury Stock | -$24M |
| Accum. Other Comp. Income | -$683.0K |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $170M |
| Minority Interest | $0 |
| TOTAL EQUITY | $170M |
| TOTAL LIABILITIES & EQUITY | $400M |
| Total Debt | $141M |
| Net Debt | $77M |
